Tricyclic antidepressants: is your patient taking them?
This analysis reveals that many prescribers are not informed when patients start and stop using TCAs.
Naltrexone had a greater effect on drinking when craving was high. These results support the role of naltrexone in reducing craving when that craving is highly salient. The role of acamprosate in reducing craving was not supported by these findings.